3 unknown. 3 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 3 | Unknown 3 |
Follow IVIg: new trials by email Literature Review of IVIg trials Research Report on IVIg
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Prednisone Plus IVIg vs. Prednisone for ITP During Pregnancy Prednisone, IVIg - Immune Thrombocytopenia | Phase 2 | Unknown | Peking University People's Hospital | 100 | 2023-10-19 | 2024-08-29 |
| Desensitization Protocol for Highly Sensitized Patients on the Waiting List for Kidney Transplant High dose IVIG and B cell depleting agents - End Stage Renal Disease | Phase 2 | Unknown | Seoul National University Hospital | 2 | 2010-01-01 | 2012-01-06 |
| IVIG in the Treatment of Metastatic Cancers of the Prostate, Colon and Melanoma IVIG, Biological Therapy - Cancer of Colon, Malignant Melanoma | Phase 2 | Unknown | GammaCan | 30 | 2005-07-01 | 2006-10-12 |
Colonic Neoplasms (1) · Kidney Failure, Chronic (1) · Melanoma (1) · Neoplasms (1) · Purpura, Thrombocytopenic, Idiopathic (1) · Urologic Neoplasms (1)
GammaCan (1) · Peking University People's Hospital (1) · Seoul National University Hospital (1)
China (1) · Israel (1) · South Korea (1)
Curie Ahn, MD (1) · Dan Aderka, M.D. (1) · Xiaohui Zhang, Professor (1)